Rankings
▼
Calendar
LSTA Q4 2023 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
LSTA
Lisata Therapeutics, Inc.
$44M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$5M
EPS (Diluted)
$-0.66
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$473,000
Balance Sheet
Total Assets
$55M
Total Liabilities
$7M
Stockholders' Equity
$48M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$6M
-$7M
+7.9%
Net Income
-$5M
-$6M
+10.4%
← FY 2023
All Quarters
Q1 2024 →